-
Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects.
Wegrzyn P, Faro C, Falcon O, Peralta CF, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:28-32. -
The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH.
Prenat Diagn 2005;25:927-9. -
Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations.
Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH.
Prenat Diagn 2005;25:365-9. -
Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound.
Peralta CF, Falcon O, Wegrzyn P, Faro C, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;25:464-7. -
First-Trimester Screening for Chromosomal Abnormalities.
Nicolaides KH.
Semin Perinatol 2005;29:190-4. -
Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation.
Falcon O, Cavoretto P, Peralta CF, Csapo B, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:755-60. -
Gestational sac volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects.
Falcon O, Wegrzyn P, Faro C, Peralta CF, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;25:546-50. -
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
Prenat Diagn 2005;25:977-83. -
Comparison of protocols for extracting circulating DNA and RNA from maternal plasma.
Chiu RW, Lui WB, El-Sheikhah A, Chan AT, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2005;51:2209-10. -
Aneuploidy screening in coelomic samples using fluorescence in situ hybridisation (FISH)
Chatzimeletiou K, Makrydimas G, Sotiriadis A, Paraskevaidis E, Nicolaides KH.
Prenat Diagn 2005;25:919-26. -
Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency.
von Kaisenberg CS, Huggon I, Hyett JA, Farzaneh F, Nicolaides KH.
Fetal Diagn Ther 1997:12:270-3. -
Fetal nuchal translucency thickness at 10-14 weeks gestation and congenital diaphragmatic hernia.
Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH.
Obstet Gynecol 1997;90:943-6. -
Management of twin pregnancies with fetal trisomies.
Sebire NJ, Snijders RJM, Santiago C, Papapanagiotou G, Nicolaides KH.
BJOG 1997;104:220-2. -
Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.
Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH.
BJOG 1997;104:741-3. -
Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks gestation)
Macintosh MC, Nicolaides KH, Noble P, Chard T, Gunn L, Illes R.
Prenat Diagn 1997;17:401-5. -
Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.
Hyett J, Moscoso G, Nicolaides KH.
Am J Med Genet 1997;69:207-16. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Blood transferrin receptor expression in chromosomally abnormal fetuses.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:282-4. -
Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.
Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:250-5. -
Fetal exomphalos at 11 to 14 weeks of gestation.
Snijders RJ, Brizot ML, Faria M, Nicolaides KH.
J Ultrasound Med 1995;14:569-74.